{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416-346-7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 110302, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 231228, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 98346, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6, "open": 0.605, "dayLow": 0.57, "dayHigh": 0.605, "regularMarketPreviousClose": 0.6, "regularMarketOpen": 0.605, "regularMarketDayLow": 0.57, "regularMarketDayHigh": 0.605, "payoutRatio": 0.0, "beta": -0.448, "volume": 44843, "regularMarketVolume": 44843, "averageVolume": 374880, "averageVolume10days": 105070, "averageDailyVolume10Day": 105070, "bid": 0.5606, "ask": 0.6076, "bidSize": 1, "askSize": 1, "marketCap": 2680513, "fiftyTwoWeekLow": 0.57, "fiftyTwoWeekHigh": 108.0, "fiftyDayAverage": 1.13428, "twoHundredDayAverage": 12.539995, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -272686, "profitMargins": 0.0, "floatShares": 452803, "sharesOutstanding": 4527130, "sharesShort": 194421, "sharesShortPriorMonth": 293829, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0429, "heldPercentInsiders": 0.15599, "heldPercentInstitutions": 0.18867001, "shortRatio": 0.42, "shortPercentOfFloat": 0.0436, "impliedSharesOutstanding": 4527130, "bookValue": -2.072, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -46591980, "trailingEps": -76.91, "lastSplitFactor": "1:75", "lastSplitDate": 1732579200, "52WeekChange": -0.99262303, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.5921, "recommendationKey": "none", "totalCash": 1932519, "totalCashPerShare": 3.19, "totalDebt": 1301145, "quickRatio": 0.586, "currentRatio": 0.639, "returnOnAssets": -1.37785, "freeCashflow": -395833, "operatingCashflow": -2873107, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "preMarketChange": 0.017799973, "preMarketChangePercent": 3.0062444, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "corporateActions": [], "preMarketTime": 1743596355, "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.3166665, "regularMarketPrice": 0.5921, "cryptoTradeable": false, "marketState": "PRE", "preMarketPrice": 0.6099, "regularMarketChange": -0.0079, "regularMarketDayRange": "0.57 - 0.605", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 374880, "fiftyTwoWeekLowChange": 0.022100031, "fiftyTwoWeekLowChangePercent": 0.038771987, "fiftyTwoWeekRange": "0.57 - 108.0", "fiftyTwoWeekHighChange": -107.4079, "fiftyTwoWeekHighChangePercent": -0.99451756, "fiftyTwoWeekChangePercent": -99.26231, "epsTrailingTwelveMonths": -76.91, "fiftyDayAverageChange": -0.54217994, "fiftyDayAverageChangePercent": -0.47799483, "twoHundredDayAverageChange": -11.947895, "twoHundredDayAverageChangePercent": -0.95278305, "priceToBook": -0.28576255, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "prevName": "Psyence Therapeutics Corp.", "nameChangeDate": "2025-04-01", "displayName": "Psyence Biomedical", "trailingPegRatio": null}